Garmyn A J, Miller M F
Department of Animal and Food Sciences, Texas Tech University, Lubbock 79409.
J Anim Sci. 2014 Jan;92(1):10-20. doi: 10.2527/jas.2013-7097. Epub 2013 Oct 24.
The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency, or what some refer to as the aggressiveness of the implant regimen administered. Within the past decade, a new class of growth promotants, known as β-adrenergic agonists (βAA), has emerged in the beef feeding industry in the United States. Currently, 2 have gained U.S. Food and Drug Administration approval for use in beef finishing diets to improve performance and carcass yields. Much like anabolic implants, these repartitioning agents can have negative effects on Warner-Bratzler shear force (WBSF), but the differences do not necessarily translate directly to consumer responses for palatability and acceptance in some instances, especially when tenderness is managed through proper postmortem aging. As researchers continued to investigate the mechanisms responsible for the impact of βAA, inevitably this led to consideration of the interaction between βAA and anabolic implants. Early work combining zilpaterol hydrochloride (ZH) with anabolic implants improved performance, carcass yield, and meat yield with additive negative effects on WBSF. Similar results were produced when pairing ZH with anabolic steroids equipped with various release patterns. As with any tool, the key to success is proper management. Certain cattle populations may be better suited to receive growth promotants such as implants and βAA, and postmortem management of subprimal cuts becomes vital when producers take more aggressive approaches to improve performance and yield. The objective of this review is to overview research findings related to the impact of growth promotant technologies on beef palatability, focusing specifically on the role of implants and βAA on carcass quality, beef tenderness, and consumer responses for meat palatability.
由于合成代谢植入物对生长性能和后续盈利能力有积极影响,其在肉牛饲养行业中一直占据着一席之地。然而,根据剂量和频率,或者一些人所说的所施用植入方案的激进程度,植入物可能会对胴体品质、剪切力和食用品质产生不利影响。在过去十年中,一类新的生长促进剂,即β-肾上腺素能激动剂(βAA),在美国肉牛饲养行业中出现。目前,有两种已获得美国食品药品监督管理局批准用于育肥牛日粮,以提高生产性能和胴体产量。与合成代谢植入物非常相似,这些重新分配剂可能会对沃纳-布拉茨勒剪切力(WBSF)产生负面影响,但在某些情况下,这些差异不一定会直接转化为消费者对适口性和接受度的反应,尤其是当通过适当的宰后成熟来控制嫩度时。随着研究人员继续研究βAA产生影响的机制,这不可避免地导致了对βAA与合成代谢植入物之间相互作用的考虑。早期将盐酸齐帕特罗(ZH)与合成代谢植入物结合的研究提高了生产性能、胴体产量和肉产量,同时对WBSF产生了累加的负面影响。当将ZH与具有不同释放模式的合成代谢类固醇配对时,也产生了类似的结果。与任何工具一样,成功的关键在于妥善管理。某些牛群可能更适合接受植入物和βAA等生长促进剂,当生产者采取更激进的方法来提高生产性能和产量时,对分割肉块的宰后管理就变得至关重要。本综述的目的是概述与生长促进技术对牛肉适口性影响相关的研究结果,特别关注植入物和βAA在胴体品质、牛肉嫩度以及消费者对肉适口性反应方面的作用。